Thu, March 28, 2024

Reni Benjamin Reiterated (BCAB) at Buy and Held Target at $12 on, Mar 28th, 2024

Reni Benjamin of JMP Securities, Reiterated "BioAtla, Inc." (BCAB) at Buy and Held Target at $12 on, Mar 28th, 2024.

Reni has made no other calls on BCAB in the last 4 months.



There is 1 other peer that has a rating on BCAB. Out of the 1 peers that are also analyzing BCAB, 0 agree with Reni's Rating of Hold.



This is the rating of the analyst that currently disagrees with Reni


  • Arthur He of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $7 on, Wednesday, March 27th, 2024